(Q41062756)

English

Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 September 2017

Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms (English)

1 reference

Europe PubMed Central

26 September 2017

author name string

Fujita H

1

1 reference

Europe PubMed Central

26 September 2017

Senju S

2

1 reference

Europe PubMed Central

26 September 2017

Yokomizo H

3

1 reference

Europe PubMed Central

26 September 2017

Saya H

4

1 reference

Europe PubMed Central

26 September 2017

Ogawa M

5

1 reference

Europe PubMed Central

26 September 2017

Matsushita S

6

1 reference

Europe PubMed Central

26 September 2017

Nishimura Y

7

1 reference

Europe PubMed Central

26 September 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

26 September 2017

European Journal of Immunology

1 reference

Europe PubMed Central

26 September 2017

28

1 reference

Europe PubMed Central

26 September 2017

1

1 reference

Europe PubMed Central

26 September 2017

305-316

1 reference

Europe PubMed Central

26 September 2017

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Cancer antigens: immune recognition of self and altered self

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Induction of anti-self-immunity to cure cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

How can cryptic epitopes trigger autoimmunity?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Biological implications of HLA-DR expression in tumours

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Peptide‐specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K‐ras p21

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Antibodies against p53 are associated with poor prognosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Nomenclature for factors of the HLA system, 1994.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Metalloproteinase-mediated release of human Fas ligand

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

p53, a potential target for tumor-directed T cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Dominance and crypticity of T cell antigenic determinants

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

DNA damage, p53 and anticancer therapies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Augmentation of immune response by an analog of the antigenic peptide in a human T-cell clone recognizing mutated Ras-derived peptides

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Generation of CD4+ cytotoxic T lymphocytes stimulated by immobilized anti-CD3 monoclonal antibody and interleukin-2 in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Serum p53 antibodies as early markers of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Serologic dissection of HLA-D specificities by the use of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Detection of a novel HLA-DQ specificity: serological and immunochemical analyses by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Identifiers

10.1002/(SICI)1521-4141(199801)28:01<305::AID-IMMU305>3.0.CO;2-3

1 reference

Europe PubMed Central

26 September 2017

release_mesh2iqflzhrlg4g3x7nzreiem

1 reference

https://api.fatcat.wiki/v0/release/mesh2iqflzhrlg4g3x7nzreiem

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41062756&oldid=1914240253"